guanylyl cyclase C targeted vaccine (TDT/Millennium/Thomas jefferson University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameguanylyl cyclase C targeted vaccine (TDT/Millennium/Thomas jefferson University)
Drug Alias NameST ligand (TDT/Millennium)colorectal cancer therapy (TDT/Millennium)guanylyl cyclase C targeted therapeutic (TDT/Millennium)GC-C
ClassificationVaccines
Mechanisms of ActionHeat-stable enterotoxin receptor modulators
TargetsHeat-stable enterotoxin receptor
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTargeted Diagnostics And Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargeted Diagnostics And TherapeuticsMillennium Pharmaceuticals IncThomas Jefferson University
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A